Managing lupus nephritis: Algorithms for conservative use of renal biopsy

Cleveland Clinic Journal of Medicine

Volumn 63, Issue 2, 1996, Pages 106-115

  Salach, Roderick H ^a   Cash, Joseph M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; METHYLPREDNISOLONE;

HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; REVIEW;

EID: 0030003552     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.63.2.106     Document Type: Review

References (43)

1. Wallace DJ, Hahn BH, Klippel JH. Lupus nephritis. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. 4th ed. Philadelphia. Lea & Febiger, 1993:542-549.
2. Iverson P, Brun C. Aspiration biopsy of the kidney. Am J Med 1951; 11:324.
3. Muehrcke RC, Kark RM, Pirani CL, Pollak VE. Lupus nephritis. A clinical and pathologic study based on renal biopsy. Medicine 1957; 6:1-145.
4. Pollak VE, Pirani CL. Renal histologic findings in SLE. Mayo Clin Proc 1969; 44:30-44.
5. Pollak VE, Pirani CL, Schwartz. The natural history of the renal manifestations of SLE. J Lab Clin Med 1964; 63:537-550.
6. Baldwin DS, Lowenstein J, Rothfield NF, Gallo G, McCluskey RT. The clinical course of the proliferative and membranous forms of lupus nephritis. Ann Intern Med 1970; 73:929-942.
7. Hayslett JP, Kashgarian M. Nephrology of systemic lupus erythematosus. In: Schrier RW, Gottschalk CW, editors. Diseases of the kidneys. 5th ed Boston, Toronto, London: Little Brown and Co, 1993:2019-2037.
8. Pollak VE, Pirani CL. Lupus nephritis: pathology, pathogenesis, climcopathologic correlations and prognosis. In: Wallace DJ, Hahn BH editors. Dubois' lupus erythematosus. 4th ed. Philadelphia: Lea & Febiger, 1993:525-541
9. Esdaile JM, Joseph L, MacKenzie T, Kashgarian M, Hayslett JP. The pathology and prognosis of lupus nephritis: information from repeat renal biopsy. Semin Arthritis Rheum 1993; 23:135-148.
10. Balow JE, Austin HA, Mueng LR, et al. Effect of treatment on the evolution of renal abnormalities in lupus nephritis. N Engl J Med 1984; 311:491-495.
11. Morel-Maroger L, Mery JP, Droz D, et al. The course of lupus nephritis: contribution of serial renal biopsies. Adv Nephrol 1976; 6:79-118
12. Appel GB, Silva FG, Pirani CL, Meltzer JI, Estes D. Renal involvement in SLE: a study of 56 patients emphasizing histologic classification. Medicine 1978; 57:371-410.
13. Esdaile JM, Levinton C, Federgreen W, Hayslett JP, Kashgarian M. The clinical and renal biopsy predictors of long-term outcome in lupus nephritis, a study of 87 patients and review of the literature. Q J Med 1989; 72:779-833.
14. Austin HA, Muenz LR, Joyce KM, Antonovych TT, Balow JE. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome Kidney Int 1984; 25:689-695.
15. McCluskey RT. Lupus nephritis. In: Sommers SL, editor. Kidney pathology (Decennial 1966-1975). New York: Appelton-Century-Crofts, 1975:456-459.
16. Churg J, Sobin LH. Renal disease. Classification and atlas of glomerular disease. Tokyo, New York: Igaku-Shoin, 1982:127-149.
17. Hayslett JP, Hardin JH, editors. Advances in systemic lupus erythematosus. Am J Kidney Dis 1982; 11:97-236
18. Ballou SP, Kushner I. The case against utility (renal biopsy): lupus nephritis. In: Narins RG, editor Controversies in nephrology and hypertension. New York: Churchill Livingstone, 1984:271-284.
19. Whiting-O'Keefe Q, Henke JE, Sheam MA, Hopper J Jr, Biava CG, Epstein WV. The informational content from renal biopsy in SLE. stepwise linear regression analysis. Ann Intern Med 1982; 96:718-723.
20. Austin HA, Muenz LR, Joyce KM, Antonovych TA, et al. Prognostic factors in lupus nephritis: contribution of renal histologic data. Am J Med 1983; 75:382-391.
21. Steinberg AD. Nephrology forum: the treatment of lupus nephritis. Kidney Int 1986; 30:769-787.
22. Nossent HC, Henzen-Logmans SC, Vroom TM, Berden JH, Swaak TJ. Contribution of renal biopsy data in predicting outcome in lupus nephritis: analysis of 116 patients. Arthritis Rheum 1990; 33:970-977.
23. Schwartz MM, Shu-Ping Lan, Bernstein J, Hill GS, Holley K, Lewis EJ. Role of pathology indices in the management of severe lupus glomerulonephritis. Kidney Int 1992; 42:743-748
24. Wernick RM, Smith DL, Houghton DC, et al. Reliability of histologic scoring for lupus nephritis, a community-based evaluation. Ann Intern Med 1993; 119:805-811.
25. McCluskey RT. The value of the renal biopsy in lupus nephritis. Arthritis Rheum 1982; 25:867-857.
26. Esdaile JM, Federgreen W, Quintal H, Suissa S, Hayslett JP, Kashgarian M. Predictors of one year outcome in lupus nephritis the importance of renal biopsy. Q J Med 1991; 81:907-918.
27. Esdaile JM, MacKenzie T, Barre P, et al. Can experienced clinicians predict the outcome of lupus nephritis? Lupus 1992; 1:205-214.
28. Mahajan SK, Ordonez NG, Feitelson PJ, Lim VS, Spargo BH, Katz AI. Lupus nephritis without clinical renal involvement. Medicine 1977; 56:493-501.
29. Leehey DJ, Katz AI, Azaran AH, Aronson AJ, Spargo BH. Silent diffuse lupus nephritis: long-term follow-up. Am J Kidney Dis 1982; 2 Suppl 1:188-196.
30. Esdaile JM, Joseph L, Macenzie T, Kashgarian M, Hayslett JP. The benefit of early treatment with immunosuppressive agents in lupus nephritis. J Rheumatol 1994; 21:1985-1986
31. Felson DT, Anderson J. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone atone in lupus nephritis: results of a pooled analysis. N Engl J Med 1984; 311:1528-1533.
32. Steinberg AD, Steinberg SC. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide verses those treated with prednisone only Arthritis Rheum 1991; 34:945-950.
33. Wallace DJ. A critique of the NIH lupus nephritis survey. Arthritis Rheum 1992; 35:605 Letter.
34. Balow JE. Treatment and monitoring of patients with lupus nephritis. Nephrol Dial Transplant 1990; 1 (Suppl): 58-59.
35. Lockwood CM, Rees AJ, Russell B, et al. Experience on the use of plasma exchange in the management of potentially fulminating glomerulonephritis and SLE. Exp Hematol 1977; 5:117.
36. Verrier-Jones J, Cummings RH, Bacon PA, et al. Evidence for a therapeutic effect of plasmapheresis in patients with systemic lupus erythematosus. Q J Med 1979; 48:555-576.
37. Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM. A controlled trial of plasmapheresis therapy in severe lupus erythematosus. The Lupus Nephritis Collaborative Study Group. N Engl J Med 1992; 326:1373-1379.
38. Schroeder JO, Euler HH, Loffler H. Synchronization of plasmapheresis and pulse cyclophosphamide in severe lupus erythematosus. Ann Intern Med 1987; 107:344-346.
39. Pollak VE, Shashi K, Hariharan S. Diffuse and focal proliferative lupus nephritis: treatment approaches and results. Nephron 1991; 59:177-193.
40. Strober S, Farinas MC, Field EH, et al. Lupus nephritis after total lymphoid irradiation: persistent improvement and reduction of steroid therapy. Ann Intern Med 1987; 107:689-690.
41. Favre H, Miescher PA, Huang YP, Chatelanat F, Mihatsch MJ. Cyclosporin in the treatment of lupus nephritis. Am J Nephrol 1989;9(Suppl 1):57-60.
42. Balletta M, Sabella D, Magri P, et al. Cyclosporine plus steroids versus steroids alone in the treatment of lupus nephritis. Contrib Nephrol 1992; 99:129-130.
43. Ponticelli C. Current treatment recommendations for lupus nephritis. Drugs 1990; 40:19-30.